ArticleChinese medical journal2017

Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy.

Jia-Nan Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.